ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 66 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96 | +118.2% | 88,234 | +193.1% | 0.01% | +66.7% |
| Q4 2022 | $44 | -99.9% | 30,103 | -25.7% | 0.01% | +50.0% |
| Q3 2022 | $44,000 | +51.7% | 40,503 | +133.7% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -42.0% | 17,328 | -29.2% | 0.00% | -50.0% |
| Q1 2022 | $50,000 | -79.7% | 24,470 | -48.5% | 0.00% | -81.8% |
| Q3 2021 | $246,000 | +23.6% | 47,542 | +139.6% | 0.02% | -4.3% |
| Q2 2020 | $199,000 | -50.7% | 19,845 | -67.2% | 0.02% | +9.5% |
| Q4 2017 | $404,000 | +75.7% | 60,473 | +115.6% | 0.02% | +90.9% |
| Q3 2017 | $230,000 | – | 28,051 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |